| NCT Number | NCT06317324 |
| Lead Sponsor | Tianjin Medical University Cancer Institute and Hospital |
| Conditions | NSCLC, Radiotherapy, Surgery |
| Enrollment | 150 participants |
| Start Date | 2023-08-01 |
| Primary Completion | 2024-08-01 (estimated) |
| Study Completion | 2026-08-01 (estimated) |
| Updated on ClinicalTrials.gov | 2024-03-19 |